177 related articles for article (PubMed ID: 33547544)
1. Structure prediction, molecular simulations of RmlD from Mycobacterium tuberculosis, and interaction studies of Rhodanine derivatives for anti-tuberculosis activity.
N H; P SR; Sura M; Daddam JR
J Mol Model; 2021 Feb; 27(3):75. PubMed ID: 33547544
[TBL] [Abstract][Full Text] [Related]
2. Ensemble-based high-throughput virtual screening of natural ligands using the Super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in
Ravichandran R; Ridzwan NFW; Mohamad SB
J Biomol Struct Dyn; 2022 Jul; 40(11):5069-5078. PubMed ID: 33382017
[TBL] [Abstract][Full Text] [Related]
3. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
[TBL] [Abstract][Full Text] [Related]
4. Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.
Wang Y; Hess TN; Jones V; Zhou JZ; McNeil MR; Andrew McCammon J
Bioorg Med Chem Lett; 2011 Dec; 21(23):7064-7. PubMed ID: 22014548
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel N-methyl carbazole tethered rhodanine derivatives as direct inhibitors of Mycobacterium tuberculosis InhA.
Shaikh MS; Kanhed AM; Chandrasekaran B; Palkar MB; Agrawal N; Lherbet C; Hampannavar GA; Karpoormath R
Bioorg Med Chem Lett; 2019 Aug; 29(16):2338-2344. PubMed ID: 31227345
[TBL] [Abstract][Full Text] [Related]
6. Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase.
Xu JF; Wang TT; Yuan Q; Duan YT; Xu YJ; Lv PC; Wang XM; Yang YS; Zhu HL
Bioorg Med Chem; 2019 Apr; 27(8):1509-1516. PubMed ID: 30846404
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
Saxena S; Abdullah M; Sriram D; Guruprasad L
J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1.
Mori M; Deodato D; Kasula M; Ferraris DM; Sanna A; De Logu A; Rizzi M; Botta M
Bioorg Med Chem Lett; 2018 Feb; 28(4):637-641. PubMed ID: 29395975
[TBL] [Abstract][Full Text] [Related]
9. Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation.
Subhedar DD; Shaikh MH; Shingate BB; Nawale L; Sarkar D; Khedkar VM; Kalam Khan FA; Sangshetti JN
Eur J Med Chem; 2017 Jan; 125():385-399. PubMed ID: 27688192
[TBL] [Abstract][Full Text] [Related]
10. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
[TBL] [Abstract][Full Text] [Related]
11. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
[TBL] [Abstract][Full Text] [Related]
12. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
Alegaon SG; Alagawadi KR; Sonkusare PV; Chaudhary SM; Dadwe DH; Shah AS
Bioorg Med Chem Lett; 2012 Mar; 22(5):1917-21. PubMed ID: 22325950
[TBL] [Abstract][Full Text] [Related]
13. Design of novel quinoline-aminopiperidine derivatives as
Wang J; Zhao C; Tu J; Yang H; Zhang X; Lv W; Zhai H
J Biomol Struct Dyn; 2019 Jul; 37(11):2913-2925. PubMed ID: 30044186
[TBL] [Abstract][Full Text] [Related]
14. Drug targeting Mycobacterium tuberculosis cell wall synthesis: genetics of dTDP-rhamnose synthetic enzymes and development of a microtiter plate-based screen for inhibitors of conversion of dTDP-glucose to dTDP-rhamnose.
Ma Y; Stern RJ; Scherman MS; Vissa VD; Yan W; Jones VC; Zhang F; Franzblau SG; Lewis WH; McNeil MR
Antimicrob Agents Chemother; 2001 May; 45(5):1407-16. PubMed ID: 11302803
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
16. Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking.
Anuradha CM; Mulakayala C; Babajan B; Naveen M; Rajasekhar C; Kumar CS
J Mol Model; 2010 Jan; 16(1):77-85. PubMed ID: 19484275
[TBL] [Abstract][Full Text] [Related]
17. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
18. Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations.
Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
Tuberculosis (Edinb); 2020 Mar; 121():101920. PubMed ID: 32279872
[TBL] [Abstract][Full Text] [Related]
19. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
[TBL] [Abstract][Full Text] [Related]
20. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
